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Introduction
In 2011 the New Zealand Health Quality & Safety Com-
mission implemented three national quality improve-
ment programmes: Hand Hygiene New Zealand, a
surgical site infection surveillance and improvement
programme and Target CLAB Zero. The Target CLAB
Zero programme, based on the use ‘bundles of care’ for
central line (CVL) placement and maintenance was
delivered across all 20 District Health Boards (DHB).
The aim was to reduce the rate of CVL-associated bac-
teremia (CLAB) to < 2 /1000 line days.
Methods
The Target CLAB Zero programme, lead by Counties
Manukau DHB and Ko Awatea, used the Institute of
Healthcare Improvement collaborative methodology. At
Auckland DHB there are three intensive care units; pae-
diatric ICU (PICU) , adult cardiothoracic and vascular
ICU (CICU) and adult medical and surgical ICU
(DCCM). A working group with nursing staff from each
unit developed a single approach to the delivery of the
programme across all three units. This involved educa-
tion of staff, auditing and feedback of compliance with
the ‘bundles’, and monitoring the rate of CLAB/1000
line days. Baseline rates for CLAB/1000 line days were
collected prospectively for two units and estimated ret-
rospectively for one.
Results
As of March 2013, 15 months after starting the colla-
borative all three units had achieved at some stage >100
days without a CLAB episode and one unit, CICU has
not had a CLAB event since February 2012. The overall
CLAB rate per quarter (Jan-Dec 2012) across all three
units was 4.2, 0, 0.45 and 1.6 CLAB/1000 line days,
respectively.
Other improvement activities include the standardiza-
tion of blood culture collection practices within the
units, updating organisation-wide CVL policy and the
development of high risk criteria for each unit.
Conclusion
The Target CLAB Zero programme has resulted in a
significant reduction in the number of CLAB/1000 line
days among ICU patients. It is now being rolled out in
theatres, emergency departments and other areas in the
hospital where CVL are placed. Implementation of this
programme has lead to a culture of cooperation
amongst the three ICU that did not exist previously.
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